A citation-based method for searching scientific literature

Gara Arteaga-Henríquez, Maria S Simon, Bianka Burger, Elif Weidinger, Annemarie Wijkhuijs, Volker Arolt, Tom K Birkenhager, Richard Musil, Norbert Müller, Hemmo A Drexhage. Front Psychiatry 2019
Times Cited: 54







List of co-cited articles
509 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
918
40


A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
25

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
518
24

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
24

Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials.
O Köhler-Forsberg, C N Lydholm, C Hjorthøj, M Nordentoft, O Mors, M E Benros. Acta Psychiatr Scand 2019
125
22


Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
320
20

Treatment-resistant depression and peripheral C-reactive protein.
Samuel R Chamberlain, Jonathan Cavanagh, Peter de Boer, Valeria Mondelli, Declan N C Jones, Wayne C Drevets, Philip J Cowen, Neil A Harrison, Linda Pointon, Carmine M Pariante,[...]. Br J Psychiatry 2019
138
18

Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
Jia Jia Liu, Ya Bin Wei, Rebecca Strawbridge, Yanping Bao, Suhua Chang, Le Shi, Jianyu Que, Bharathi S Gadad, Madhukar H Trivedi, John R Kelsoe,[...]. Mol Psychiatry 2020
96
18

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
473
18

Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
Ebrahim Haroon, Alexander W Daguanno, Bobbi J Woolwine, David R Goldsmith, Wendy M Baer, Evanthia C Wommack, Jennifer C Felger, Andrew H Miller. Psychoneuroendocrinology 2018
107
16

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
510
16

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
222
16



A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
14

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
279
14

Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials.
Shuang Bai, Wenliang Guo, Yangyang Feng, Hong Deng, Gaigai Li, Hao Nie, Guangyu Guo, Haihan Yu, Yang Ma, Jiahui Wang,[...]. J Neurol Neurosurg Psychiatry 2020
47
14

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
198
12

Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels.
Emanuele Felice Osimo, Luke James Baxter, Glyn Lewis, Peter B Jones, Golam M Khandaker. Psychol Med 2019
156
12

What does plasma CRP tell us about peripheral and central inflammation in depression?
Jennifer C Felger, Ebrahim Haroon, Trusharth A Patel, David R Goldsmith, Evanthia C Wommack, Bobbi J Woolwine, Ngoc-Anh Le, Rachel Feinberg, Malu G Tansey, Andrew H Miller. Mol Psychiatry 2020
125
12

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, Michael Maes, Marco Solmi, Nicola Veronese, Nayanna Q de Andrade, Gerwyn Morris, Brisa S Fernandes, André R Brunoni,[...]. Mol Neurobiol 2018
204
12

Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.
J C Felger, Z Li, E Haroon, B J Woolwine, M Y Jung, X Hu, A H Miller. Mol Psychiatry 2016
279
12

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
12

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D V Sheehan, Y Lecrubier, K H Sheehan, P Amorim, J Janavs, E Weiller, T Hergueta, R Baker, G C Dunbar. J Clin Psychiatry 1998
12

Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.
Jennifer C Felger, Michael T Treadway. Neuropsychopharmacology 2017
162
12

Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients.
Annamaria Cattaneo, Clarissa Ferrari, Rudolf Uher, Luisella Bocchio-Chiavetto, Marco Andrea Riva, Carmine M Pariante. Int J Neuropsychopharmacol 2016
74
12

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
528
11

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
C L Raison, R Dantzer, K W Kelley, M A Lawson, B J Woolwine, G Vogt, J R Spivey, K Saito, A H Miller. Mol Psychiatry 2010
420
11

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi, Abbas Ali Nasehi, Aboulfazl Ghoreishi, Bahman Salehi, Soodeh Mohebbi-Rasa, Maedeh Raznahan, Abbas Kamalipour. Depress Anxiety 2009
247
11

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.
Jonathan B Savitz, T Kent Teague, Masaya Misaki, Matt Macaluso, Brent E Wurfel, Matt Meyer, Douglas Drevets, William Yates, Ondria Gleason, Wayne C Drevets,[...]. Transl Psychiatry 2018
69
11


Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression.
Mona Moieni, Michael R Irwin, Ivana Jevtic, Richard Olmstead, Elizabeth C Breen, Naomi I Eisenberger. Neuropsychopharmacology 2015
154
11


Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.
Neil A Harrison, Lena Brydon, Cicely Walker, Marcus A Gray, Andrew Steptoe, Hugo D Critchley. Biol Psychiatry 2009
462
11

A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
11

Neuroinflammation in Bipolar Depression.
Francesco Benedetti, Veronica Aggio, Maria Luisa Pratesi, Giacomo Greco, Roberto Furlan. Front Psychiatry 2020
61
11

Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder.
L A Carvalho, V Bergink, L Sumaski, J Wijkhuijs, W J Hoogendijk, T K Birkenhager, H A Drexhage. Transl Psychiatry 2014
77
11

Clinical characteristics of inflammation-associated depression: Monocyte gene expression is age-related in major depressive disorder.
Laura Grosse, Livia A Carvalho, Annemarie J M Wijkhuijs, Silja Bellingrath, Tillmann Ruland, Oliver Ambrée, Judith Alferink, Thomas Ehring, Hemmo A Drexhage, Volker Arolt. Brain Behav Immun 2015
49
12

Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
Ebrahim Haroon, James R Welle, Bobbi J Woolwine, David R Goldsmith, Wendy Baer, Trusharth Patel, Jennifer C Felger, Andrew H Miller. Neuropsychopharmacology 2020
50
12

Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward.
Naomi I Eisenberger, Elliot T Berkman, Tristen K Inagaki, Lian T Rameson, Nehjla M Mashal, Michael R Irwin. Biol Psychiatry 2010
331
11

Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls.
Emanuele F Osimo, Toby Pillinger, Irene Mateos Rodriguez, Golam M Khandaker, Carmine M Pariante, Oliver D Howes. Brain Behav Immun 2020
105
11

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
11

Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders.
Gayle M Wittenberg, Annie Stylianou, Yun Zhang, Yu Sun, Ashutosh Gupta, P S Jagannatha, Dai Wang, Benjamin Hsu, Mark E Curran, Shahid Khan,[...]. Mol Psychiatry 2020
50
12

Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
Paula Kopschina Feltes, Janine Doorduin, Hans C Klein, Luis Eduardo Juárez-Orozco, Rudi Ajo Dierckx, Cristina M Moriguchi-Jeckel, Erik Fj de Vries. J Psychopharmacol 2017
109
9

Immune system to brain signaling: neuropsychopharmacological implications.
Lucile Capuron, Andrew H Miller. Pharmacol Ther 2011
640
9

Novel therapeutic targets in depression: minocycline as a candidate treatment.
Joanna K Soczynska, Rodrigo B Mansur, Elisa Brietzke, Walter Swardfager, Sidney H Kennedy, Hanna O Woldeyohannes, Alissa M Powell, Marena S Manierka, Roger S McIntyre. Behav Brain Res 2012
114
9

Integrating neuroimmune systems in the neurobiology of depression.
Eric S Wohleb, Tina Franklin, Masaaki Iwata, Ronald S Duman. Nat Rev Neurosci 2016
284
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.